We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

98 hedge funds and large institutions have $228M invested in Albany Molecular Research Inc in 2013 Q2 according to their latest regulatory filings, with 98 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49% less call options, than puts

Call options by funds: $317K | Put options by funds: $627K

Holders
98
Holders Change
+98
Holders Change %
–
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
98
Increased
–
Reduced
–
Closed
–
Calls
$317K
Puts
$627K
Net Calls
-$310K
Net Calls Change
-$310K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

AMRI Hedge Fund Activity: Q2 2013 in Review

98 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2013, worth a combined $228M.

Buyers outnumbered sellers: 98 funds opened new AMRI positions and 0 closed out — a net gain of 98 holders — while 0 added to existing stakes and 0 trimmed.

  • 98 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $228M of Albany Molecular Research Inc stock for Q2 2013.
  • 98 funds opened new Albany Molecular Research Inc positions in Q2 2013 and 0 closed out, a net change of +98 holders.

Based on aggregated 13F filings for Q2 2013.